Willingness and barriers to COVID-19 vaccination among Libyan adults: A cross-sectional survey
Mustafa A. Alssageer, Khadeja M. Mohammed, Nour Alhoda E. Masoud
Abstract
The success of COVID-19 vaccination programs depends on public acceptance, yet evidence from southern Libya remains limited. This study aimed to examine public perceptions, attitudes, and willingness toward COVID-19 vaccination among adults in urban and rural areas of southern Libya. A cross-sectional survey of adults in Sebha and the surrounding areas was conducted. Data were analysed using descriptive statistics and chi-square tests. A total of 785 questionnaires were distributed, of which 689 were completed and returned, yielding a response rate of 87.8%. The internet was the most commonly reported source of information about COVID-19 vaccination (58.2%), followed by television (25.4%). Overall, 64.6% of participants expressed willingness to receive the COVID-19 vaccine, while 35.4% were unwilling. Vaccine willingness was significantly associated with age group, marital status, place of residence, and education level. The most common reasons for acceptance were protection against COVID-19 infection (33.0%), free vaccine availability (20.0%), and prevention of transmission to others (15.8%). Among those who refused, the leading reason was concern about vaccine safety and/or side effects (50.0%), followed by preference to wait and observe effects in others (14.3%), doubts about effectiveness (10.3%), and general vaccine distrust (9.9%). Regarding opinions, 50.4% agreed that COVID-19 vaccination was important, 50.9% agreed that everyone should receive the vaccine once it is available, and 37.3% supported mandatory vaccination. This study reveals moderate willingness to receive COVID-19 vaccines among adults in southern Libya, with safety concerns and mistrust as key barriers. Targeted campaigns that engage healthcare professionals and counter misinformation are urgently needed. Importantly, these barriers extend beyond COVID-19, affecting routine and future vaccinations. Given Libya's fragile health system, these efforts must be integrated into a comprehensive national immunization plan to build sustainable vaccine confidence and resilience in the health system.
Keywords
References
- Lone SA, Ahmad A. COVID-19 pandemic - an African perspective. Emerging Microbes and Infections. 2020; 9(1): 1300-1308. doi: 10.1080/22221751.2020.1775132
- Moore M, Gelfeld B, Okunogbe A, Paul C. Identifying future disease hot spots: Infectious disease vulnerability index, Rand Health Quarterly. 2017; 6(3): 5. PMID: 28845357; PMCID: PMC5568150.
- Centers for Disease Control and Prevention. Ten great public health achievements-United States, 1900-1999. Morbidity and Mortality Weekly Report. 1999; 48(12): 241-243. PMID: 10220250.
- Andre FE, Booy R, Bock HL, Clemens J, Datta SK, John TJ, et al. Vaccination greatly reduces disease, disability, death and inequity worldwide. Bulletin of the World Health Organization. 2008; 86(2): 140-146. doi: 10.2471/blt. 07.040089
- Zhou W, Pool V, Iskander JK, English-Bullard R, Ball R, Wise RP, et al. Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)-United States, 1991-2001. Morbidity and Mortality Weekly Report: Surveillance Summaries. 2003; 52(1): 1-24. PMID: 12825543.
- Jackson LA, Anderson EJ, Rouphael NG, Roberts PC, Makhene M, Coler RN, et al. An mRNA vaccine against SARS-CoV-2 - Preliminary report. The New England Journal of Medicine. 2020; 383(20): 1920-1931. doi: 10.1056 /NEJMoa2022483
- Yuen K-S, Ye Z-W, Fung S-Y, Chan C-P, Jin D-Y. SARS-CoV-2 and COVID-19: The most important research questions. Cell and Bioscience. 2020; 10(40). doi: 10.1186/s13578-020-00404-4
- Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020; 395(10223): 497-506. doi: 10.1016/S0140-6736(20)30183-5
- Fauci AS, Lane HC, Redfield RR. COVID-19 - Navigating the uncharted. The New England Journal of Medicine. 2020; 382(13): 1268-1269. doi: 10.1056/NEJMe2002387
- Fine P, Eames K, Heymann DL. Herd immunity: A rough guide. Clinical Infectious Diseases. 2011; 52(7): 911-916. doi: 10.1093/cid/cir007
- Yoda T, Katsuyama H. Willingness to receive COVID-19 vaccination in Japan. Vaccines. 2021; 9(1): 48. doi: 10.3390/vaccines9010048
- Alfageeh EI, Alshareef N, Angawi K, Alhazmi F, Chirwa GC. Acceptability of a COVID-19 vaccine among the Saudi population. Vaccines. 2021; 9(3): 226. doi: 10.3390/vaccines9030226
- Syed Alwi SAR, Rafidah E, Zurraini A, Juslina O, Brohi IB, Lukas S. A survey on COVID-19 vaccine acceptance and concern among Malaysians. British Medical Journal: Public Health. 2021; 21(1): 1129. doi: 10.1186/s12889-021-11071-6
- Eibensteiner F, Ritschl V, Nawaz FA, Fazel SS, Tsagkaris C, Kulnik ST, et al. People’s willingness to vaccinate against COVID-19 despite their safety concerns: Twitter poll analysis. Journal of Medical Internet Research. 2021; 23(4): e28973. doi: 10.2196/28973
- Barry V, Dasgupta S, Weller DL, Kris JL, Cadwell BL, Rose C, et al. Patterns in COVID-19 vaccination coverage, by social vulnerability and urbanicity - United States, December 14, 2020-May 1, 2021. Morbidity and Mortality Weekly Report. 2021; 70(22): 818-824. doi: 10.15585/mmwr.mm7022e1
- Wake AD. The willingness to receive COVID-19 vaccine and its associated factors: Vaccination refusal could prolong the war of this pandemic - A systematic review. Risk Management and Healthcare Policy. 2021; 14: 2609-2623. doi: 10.2147/RMHP.S311074
- Wang J, Jing R, Lai X, Zhang H, Lyu Y, Knoll MD, Fang H. Acceptance of COVID-19 vaccination during the COVID-19 pandemic in China. Vaccines. 2020; 8(3): 482. doi: 10.3390/vaccines8030482
- Abedin M, Islam MA, Rahman FN, Reza HM, Hossain MZ, Rahman MA, et al. Willingness to vaccinate against COVID-19 among Bangladeshi adults. PLoS ONE. 2021; 16(4), e0250495. doi: 10.1371/journal.pone.0250495
- Zintel S, Flock C, Arbogast AL, Forster A, von Wagner C, Sieverding M. Gender differences in the intention to get vaccinated against COVID-19: A systematic review and meta-analysis. Zeitschrift für Gesundheitswissenschaften. 2022: 1-25. doi: 10.1007/s10389-021-01677-w
- Poland G, Jacobson RM. Understanding those who do not understand: A brief review of the anti-vaccine movement. Vaccine. 2001; 19(17-19): 2440-2445. doi: 10.1016/S0264-410X(00)00469-2
- MacDonald NE. Vaccine hesitancy: Definition, scope and determinants. Vaccine. 2015; 33(34): 4161-4164. doi: 10.1016/j.vaccine.2015.04.036
- Dror AA, Eisenbach N, Taiber S, Morozov NG, Mizrachi M, Zigron A, et al. Vaccine hesitancy: The next challenge in the fight against COVID-19. European Journal of Epidemiology. 2020; 35(8): 775-779. doi: 10.1007/s10654-020-00671-y
- Al-Mohaithef M, Padhi BK, Ennaceur SA. Demographics of COVID-19 vaccine hesitancy during the second wave of COVID-19 pandemic: A cross-sectional web-based survey in Saudi Arabia. medRxiv (Preprint). 2021; doi: 10.1101/2021.04.20.21255781
- Murphy J, Vallières F, Bentall RP, Shevlin M, McBride O, Hartman TK, et al. Psychological characteristics associated with COVID-19 vaccine hesitancy and resistance in Ireland and the United Kingdom. Nature Communications. 2021; 12(1): 29. doi: 10.1038/s41467-020-20226-9
- Al-Mohaithef M, Padhi BK. Determinants of COVID-19 vaccine acceptance in Saudi Arabia: A web-based national survey. Journal of Multidisciplinary Healthcare. 2020; 13: 1657-1663. doi: 10.2147/JMDH.S276771
- Wilson SL, Wiysonge C. Social media and vaccine hesitancy. British Medical Journal: Global Health. 2020; 5(10): e004206. doi: 10.1136/bmjgh-2020-004206
- Limbu YB, Gautam RK, Pham L. The health belief model applied to COVID-19 vaccine hesitancy: A systematic review. Vaccines (Basel). 2022; 10(6): 973. doi: 10.3390/vaccines10060973
- Alhaddad FE, Abuleid KM. Evaluation of adverse effects of AstraZeneca COVID-19 vaccine after the first dose in Libyan adults:a cross-sectional study. Mediterranean Journal of Pharmacy and Pharmaceutical Sciences. 2022; 2(4): 65-69. doi: 10.5281/zenodo.7479778
- Omran EAA, Alshebani AMA, Almajdoub OH. Potential risk factors for mortality in patients with COVID-19: A retrospective study. Mediterranean Journal of Pharmacy and Pharmaceutical Sciences. 2022; 2(1): 37-43. doi: 10.5281/zenodo.6399474
- Taeb ST, Alamory MM, Alamay ZM, Nafae SSH. Assessing the readiness of community pharmacists in Libya for vaccine administration: Barriers and opportunities. Mediterranean Journal of Pharmacy and Pharmaceutical Sciences. 2025; 5(1): 65-74. doi: 10.5281/zenodo.14695845
- Benomran EA, Nagah TAM, Arboleda-Tinay MC, Gusbi NA, El Jali T. An exploration of selected variables as a predictor of COVID-19 vaccination rollouts: A correlational study. Mediterranean Journal of Medical Research. 2026; 3(2): 176-183. doi: 10.5281/zenodo.20467289
Submitted date:
03/08/2026
Reviewed date:
08/23/2026
Accepted date:
08/05/2026
Publication date:
08/04/2026
